Thomas R. Trotter
President & Chief Executive Officer

Thomas R. Trotter joined AngioScore in August 2005 as President and CEO.

Mr. Trotter brings to AngioScore more than 30 years experience in the medical device business. Most recently, he served as President and CEO of OrthoLogic, Inc., a public orthopedics company. Prior to OrthoLogic, Mr. Trotter worked for Mallinckrodt, Inc. as President of the Critical Care Division, which included 2500 employees and over $400 million in annual revenues. He joined Mallinckrodt via the acquisition of Diamond Sensor Systems, a venture-backed medical device company in the blood chemistry analysis business, where he served as President and CEO. Previously, Mr. Trotter worked for Shiley, Inc., then a division of Pfizer, where he managed the worldwide cardiopulmonary business.

Mr. Trotter holds an MBA from Pepperdine University and a B.S. in business administration from the University of Maryland. He is also a senior fellow of the Holmes Society at Harvard University.

Doug Alleavitch
Vice President, Manufacturing

Doug Alleavitch serves as the Vice President of Manufacturing for the company.

Mr. Alleavitch has had a long and successful career in the medical products and medical device business with over 25 years experience in Production, Manufacturing Engineering and Quality. He joined AngioScore in August, 2007 as Senior Director of Manufacturing and was promoted to the position of Vice President of Manufacturing in April 2009. Prior to joining AngioScore, he was Director of Production for Boston Scientific, a major worldwide supplier of medical devices. Prior to that time he spent 17 years serving in various senior management roles with Baxter Healthcare. Mr. Alleavitch holds a B.S. degree in Chemical Engineering from Cornell University as well as a Master’s Degree in Chemical Engineering from the Illinois Institute of Technology and a Master’s Degree in Industrial Engineering and MBA from the University of Illinois at Chicago.

James B. Andrews
Vice President & Chief Financial Officer

Jim Andrews serves as Vice President and Chief Financial Officer of AngioScore.

Previously, Mr. Andrews was the Vice President, Finance and Chief Financial Officer of Orquest, Inc., an innovative medical technology company dedicated to setting new standards of care in orthopedics through biological solutions. From 1995 – 2004, Mr. Andrews held a variety of positions with Orquest and was an integral member of the team which sold Orquest to DePuy Acromed, a wholly owned subsidiary of Johnson & Johnson.

Mr. Andrews also founded Andrews and Associates, a financial management consulting firm specializing in senior management consulting in the life science industry. He started his career working four years in Big 4 public accounting where he became a Certified Public Accountant. Mr. Andrews has a B.S. in Business (specialty accounting) from the University of Colorado.

Karin J. Gastineau
Vice President, Medical, Regulatory, and Quality

Karin J. Gastineau serves as Vice President, Medical, Regulatory, and Quality and provides the company with strategic insight, leadership, and direction for its worldwide regulatory, quality, and clinical activities.

Ms. Gastineau brings to the company over 23 years experience in the therapeutic medical device industry and has an outstanding background in all aspects of medical, regulatory, and quality affairs.  Prior to joining AngioScore, Ms. Gastineau was a well known and highly respected Regulatory Affairs and Compliance Consultant in the S.F. Bay Area.  Previously, she was Director of Regulatory Affairs for Angiotech Pharmaceuticals where she developed global regulatory strategies for novel device-drug combination products for cardiovascular and general surgery applications.  Ms. Gastineau was the Director of Regulatory Affairs, Quality Control and Quality Assurance for Cohesion Technologies, and was a veteran at Collagen Corporation working in regulatory affairs, clinical research, business development, and intellectual property and licensing.  Ms. Gastineau holds a B.S. degree from the University of California at Berkeley and is a graduate of the Northwestern University Kellogg School of Management, Regulatory Executive Management Program.

Gary Gershony, MD, FACC
Chief Medical Officer

Dr. Gary Gershony serves as the Chief Medical Officer of AngioScore, is a Co-Founder of the company, and is a practicing Interventional Cardiologist at John Muir Medical Center, Walnut Creek, CA.

Previously, Dr. Gershony was the founder of Vascular Solutions, Inc. a public medical device company. Dr. Gershony was the principal inventor of Vascular Solutions’ flagship Duett™ Vascular Sealing Device and from 1996 – 2002 Dr. Gershony served as the company’s Medical Director.

Dr. Gershony grew up in Toronto, Canada and attended the University of Toronto where he graduated from medical school in 1979 at age 23. He continued his training in internal medicine and general cardiology at the University of Toronto and The Toronto Hospital. He also served as Chief Medical Resident from 1983-1984. Dr. Gershony continued his training in invasive and interventional cardiology, serving a fellowship at Emory University in Atlanta under the auspices of Dr. Andreas Gruentzig, the inventor of coronary angioplasty. From 1994-1998, Dr. Gershony was Director of the Cardiac Catheterization Laboratories and Interventional Cardiology at the University of California, Davis, Medical Center.

Dr. Gershony is board certified in interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association Council on Clinical Cardiology and the Society for Cardiac Angiography and Interventions. Dr. Gershony has published over 70 articles in the field of cardiology, is the author of six issued patents and has lectured widely on the latest treatments for heart disease. He also serves on the adjunct faculty of the Stanford Biodesign Innovation Program.

Michael D. Gioffredi
Vice President of Sales and Marketing

Michael D. Gioffredi serves as Vice President of Sales and Marketing of AngioScore.

Mr. Gioffredi has been in the medical device business for over 25 years. He began his career with Pfizer, spent ten years at Bard (USCI) and later served as Vice President of Marketing at Laserscope. He was Vice President of Sales and Marketing at Britesmile before moving on to Cardiac Science where, over the last several years, he served as Vice President, Worldwide Sales and Marketing and managed a department which included over 80 professionals. Mr. Gioffredi holds a B.A. in Business Administration from California State University at Fullerton.

Feridun Ozdil, Ph.D
Vice President of Research & Development, Chief Scientific Officer

Dr. Ozdil recently joined AngioScore as Vice President of Research & Development and Chief Scientific Officer. In this capacity, he is responsible for all product development activities for the company. Prior to joining AngioScore, Dr. Ozdil served as Senior Director of Research and Development for Medtronic Vascular, based in Santa Rosa, California. He joined Medtronic via their acquisition of AVE in 1999. Dr. Ozdil has over 15 years of product development experience which includes an outstanding background in catheter and stent development as well as drug coating technologies. He holds an M.S. degree and a Ph.D from the University of Florida.